Witte T - Search Results

1

Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.

Aringer M, Burkhardt H, Burmester GR, Fischer-Betz R, Fleck M, Graninger W, Hiepe F, Jacobi AM, Kötter I, Lakomek HJ, Lorenz HM, Manger B, Schett G, Schmidt RE, Schneider M, Schulze-Koops H, Smolen JS, Specker C, Stoll T, Strangfeld A, Tony HP, Villiger PM, Voll R, Witte T, Dörner T. Aringer M, et al. Among authors: witte t. Lupus. 2012 Apr;21(4):386-401. doi: 10.1177/0961203311426569. Epub 2011 Nov 9. Lupus. 2012. PMID: 22072024 Review.

2

Prognostic parameters for flare in systemic lupus erythematosus.

Mirzayan MJ, Schmidt RE, Witte T. Mirzayan MJ, et al. Among authors: witte t. Rheumatology (Oxford). 2000 Dec;39(12):1316-9. doi: 10.1093/rheumatology/39.12.1316. Rheumatology (Oxford). 2000. PMID: 11136872

3

Immunoglobulin-like transcripts 6 (ILT6) polymorphism influences the anti-Ro60/52 autoantibody status in South Indian SLE patients.

Devaraju P, Witte T, Schmidt RE, Gulati R, Negi VS. Devaraju P, et al. Among authors: witte t. Lupus. 2014 Oct;23(11):1149-55. doi: 10.1177/0961203314538107. Epub 2014 Jun 4. Lupus. 2014. PMID: 24899637

4

Thrombomodulin in systemic lupus erythematosus: association with clinical and laboratory parameters.

Witte T, Hartung K, Sachse C, Fricke M, Buyny S, Deicher H, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE. Witte T, et al. Rheumatol Int. 1999;19(1-2):15-8. doi: 10.1007/s002960050092. Rheumatol Int. 1999. PMID: 10651075

5

Association of IgA anti-dsDNA antibodies with vasculitis and disease activity in systemic lupus erythematosus. SLE Study Group.

Witte T, Hartung K, Matthias T, Sachse C, Fricke M, Deicher H, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE. Witte T, et al. Rheumatol Int. 1998;18(2):63-9. doi: 10.1007/s002960050059. Rheumatol Int. 1998. PMID: 9782535

6

IgM anti-dsDNA antibodies in systemic lupus erythematosus: negative association with nephritis. SLE Study Group.

Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Deicher H, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE. Witte T, et al. Rheumatol Int. 1998;18(3):85-91. doi: 10.1007/s002960050063. Rheumatol Int. 1998. PMID: 9833247

7

Rheumatoid factors in systemic lupus erythematosus: association with clinical and laboratory parameters. SLE study group.

Witte T, Hartung K, Sachse C, Matthias T, Fricke M, Kalden JR, Lakomek HJ, Peter HH, Schmidt RE. Witte T, et al. Rheumatol Int. 2000;19(3):107-11. doi: 10.1007/s002960050112. Rheumatol Int. 2000. PMID: 10776689

8

IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.

Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE. Witte T, et al. J Rheumatol. 2000 Nov;27(11):2617-20. J Rheumatol. 2000. PMID: 11093442

9

CD8alpha+beta(low) effector T cells in systemic lupus erythematosus.

Werwitzke S, Tiede A, Jacobs R, Zielinska-Skowronek M, Buyny S, Schmidt RE, Witte T. Werwitzke S, et al. Among authors: witte t. Scand J Immunol. 2008 May;67(5):501-8. doi: 10.1111/j.1365-3083.2008.02093.x. Scand J Immunol. 2008. PMID: 18405327 Free article.

10

[Secondary immunodeficiency in rheumatological diseases].

Ernst D, Schmidt RE, Witte T. Ernst D, et al. Among authors: witte t. Z Rheumatol. 2013 Sep;72(7):634-40, 642. doi: 10.1007/s00393-013-1160-7. Z Rheumatol. 2013. PMID: 23942561 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,131 results

Search Page